AG
SGMO

Advisor Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Advisor Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$31K Hold
3,750
– – ﹤0.01% 3718
2019
Q3 		$35K Sell
3,750
-250
-6% -$2.81K ﹤0.01% 3637
2019
Q2 		$43K Sell
4,000
-680
-15% -$7.23K ﹤0.01% 3483
2019
Q1 		$45K Buy
4,680
+3,230
+223% +$33K ﹤0.01% 3470
2018
Q4 		$17K Hold
1,450
– – ﹤0.01% 3927
2018
Q3 		$25K Buy
1,450
+500
+53% +$7.6K ﹤0.01% 3754
2018
Q2 		$14K Sell
950
-990
-51% -$16.4K ﹤0.01% 3915
2018
Q1 		$37K Hold
1,940
– – ﹤0.01% 3299
2017
Q4 		$32K Buy
1,940
+940
+94% +$14K ﹤0.01% 3399
2017
Q3 		$15K Hold
1,000
– – ﹤0.01% 3740
2017
Q2 		$9K Hold
1,000
– – ﹤0.01% 3991
2017
Q1 		$5K Buy
+1,000
New +$4.01K ﹤0.01% 4122

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Group's SGMO Position: Q4 2019 in Review

Advisor Group held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q4 2019 at 3,750 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3718.

Advisor Group first reported a position in SGMO in Q1 2017 and has held it in 12 quarters since. The position peaked at $45K in Q1 2019. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Advisor Group held 3,750 shares of SANGAMO THERAPEUTICS INC worth $31K as of Q4 2019.
  • Advisor Group left its SANGAMO THERAPEUTICS INC share count unchanged in Q4 2019.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3718 holding.
  • Advisor Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2017 and has held it in 12 quarters since.
  • Advisor Group's SANGAMO THERAPEUTICS INC position peaked at $45K in Q1 2019.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.